Abeona Therapeutics (ABEO) Receivables - Other (2020 - 2025)

Historic Receivables - Other for Abeona Therapeutics (ABEO) over the last 6 years, with Q3 2025 value amounting to $1.6 million.

  • Abeona Therapeutics' Receivables - Other rose 18.6% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 18.6%. This contributed to the annual value of $1.6 million for FY2024, which is 2380.95% down from last year.
  • Abeona Therapeutics' Receivables - Other amounted to $1.6 million in Q3 2025, which was up 18.6% from $1.6 million recorded in Q2 2025.
  • In the past 5 years, Abeona Therapeutics' Receivables - Other ranged from a high of $26.3 million in Q2 2022 and a low of $519000.0 during Q1 2023
  • Over the past 5 years, Abeona Therapeutics' median Receivables - Other value was $2.1 million (recorded in 2023), while the average stood at $6.7 million.
  • Per our database at Business Quant, Abeona Therapeutics' Receivables - Other soared by 77666.67% in 2022 and then tumbled by 9201.52% in 2023.
  • Over the past 5 years, Abeona Therapeutics' Receivables - Other (Quarter) stood at $3.0 million in 2021, then surged by 776.67% to $26.3 million in 2022, then tumbled by 92.02% to $2.1 million in 2023, then fell by 23.81% to $1.6 million in 2024, then increased by 1.0% to $1.6 million in 2025.
  • Its Receivables - Other stands at $1.6 million for Q3 2025, versus $1.6 million for Q2 2025 and $1.6 million for Q1 2025.